Página 4 - Melhores Rastreio do cancro médicos - TOP-120 médicos

O médico é oncologista especializado no tratamento de cânceres de mama, pulmão e gastrointestinais. Atualmente, o médico pratica no Hospital Universitário Istinye Liv.

Com uma carreira que abrange várias instituições renomadas, o médico atuou como Especialista em Medicina Interna no Hospital Estadual de Malatya, médico na Clínica de Oncologia de Ancara e membro do Departamento de Oncologia no Hospital Regional de Treinamento e Pesquisa de Erzurum.

O médico formou-se na Faculdade de Medicina da Universidade de Selcuk e alcançou o título de Professor Associado em 2016.

Lee Ji Hyun, MD, is a breast and thyroid surgeon. Dr. Lee is Head of Breast and Thyroid Surgery at Naeun Hospital. Clinical focus includes benign breast disease, breast cancer, and tumor surgery. Additional areas include benign thyroid disease, thyroid cancer, and parathyroid disorders. Skills include Mammotome procedures, axillary node management, and breast and thyroid ultrasound.

Education and training: Yonsei University College of Medicine. Internship and general surgery residency at Yonsei University Severance Hospital. Short-term clinical training at the Affiliated Hospital of the Cancer Research Institute in Japan.

Key roles: Chief of General Surgery at Incheon Christian Hospital and General Surgery Specialist at Cheil Hospital. Director of the Breast Center and Chief of the Department of Surgery at Samsung Cheil Hospital. Chief of General Surgery and Deputy Director of Clinical Services at Cheil Hospital. Outpatient Professor of Surgery at CHA Gangnam Medical Center, CHA University. Chief of General Surgery at Daejeong Hospital.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Dr. Victor Alexander Krol - Chefe de Gastroenterologia, Medicina Interna e do Centro de Tratamento da Obesidade no Hospital Martinus

Dr. Victor Alexander Krol é um especialista altamente qualificado, liderando os departamentos de gastroenterologia e medicina interna. Com muitos anos de experiência e profundo conhecimento na sua área, o Dr. Krol estabeleceu-se como um especialista de renome, proporcionando aos pacientes tratamento abrangente e uma abordagem individualizada. Ele utiliza ativamente os métodos mais recentes de diagnóstico e tratamento de doenças do trato gastrointestinal, metabolismo, assim como doenças dos sistemas cardiovascular e respiratório.

O Dr. Krol é também o diretor do Centro de Tratamento da Obesidade certificado no Hospital Martinus, que oferece tratamentos cirúrgicos e endoscópicos para a obesidade. O centro utiliza tecnologia avançada para diagnosticar e tratar a obesidade (adipose), incluindo métodos como cirurgia bariátrica, perda de peso endoscópica, e programas especializados para pacientes com diferentes estágios de obesidade. O centro está certificado segundo padrões elevados e tem resultados excelentes no tratamento desta doença grave.

O Departamento de Gastroenterologia, liderado pelo Dr. Krol, diagnostica e trata doenças do estômago, intestinos, fígado, pâncreas e vesícula biliar. Os médicos do departamento utilizam uma ampla gama de métodos, incluindo procedimentos endoscópicos, ultrassonografia e outras tecnologias modernas de diagnóstico.

O Departamento de Medicina Interna cobre uma ampla variedade de doenças, incluindo cardiologia, diabetologia, infectologia, e terapia de doenças respiratórias e renais. O Dr. Krol e sua equipe fornecem uma abordagem abrangente ao tratamento usando os métodos mais avançados da medicina.

Graças ao seu elevado profissionalismo e abordagem humanizada a cada paciente, o Dr. Krol desfruta merecidamente do respeito de colegas e pacientes.

O médico é um especialista líder no tratamento do linfoma não Hodgkin e se especializa no tratamento de distúrbios sanguíneos. Com mais de 30 anos de prática, o médico lidera o setor de Hematologia na Clínica Nordwest, focando em cuidados e pesquisas hematológicas avançadas.<\/p>

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

O médico é oncologista clínico e radioterapeuta com 33 anos de experiência, especializado em oncologia e radioterapia. Formou-se no Hospital Universitário Hadassah em Jerusalém, Israel, e possui qualificações em oncologia e radioterapia.<\/p>

Atualmente, atua como chefe do Centro de Câncer Gastrointestinal e também é médico sênior no Departamento de Oncologia do Hospital Universitário Hadassah. Completou os exames de certificação em oncologia e radioterapia e é membro de várias sociedades profissionais, incluindo a Sociedade Israelense de Oncologia Clínica e a Associação Israelense de Câncer.<\/p>

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Qasim Wasim holds an MBBS and master’s and PhD degrees in general surgery from Dalian Medical University. He is a PMDC board-certified general practitioner with over 10 years of experience. He served as a resident at Shaikh Zayed Medical Complex and at Nawaz Sharif Social Security Hospital in Lahore.

He manages cases in internal medicine, general surgery, obstetrics and gynecology, pediatrics, and dermatology. He also handles emergencies such as trauma, fractures, cardiac events, and burns. He is multilingual and serves an international community. He has authored over eight SCI-indexed research papers on intestinal ischemia–reperfusion injury and surgical biomechanics.

O médico lidera o Centro de Melanoma e Imunoterapia do Câncer no Centro Médico Hadassah, focando em pesquisa inovadora e tratamento de pacientes. Especializando-se no estudo da família de receptores SLAM, o médico está na vanguarda da pesquisa de resposta imunológica contra o câncer.<\/p>

Envolvido no tratamento de pacientes com melanoma com novas imunoterapias, o médico trabalha com uma equipe de clínicos e pesquisadores. Esta colaboração proporciona acesso imediato a dados clínicos e tecidos derivados de pacientes, melhorando os esforços de pesquisa translacional.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.